Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PLAP antibody

ALPP Reactivity: Human FACS, IF, IHC (p) Host: Mouse Monoclonal ALPP-870 unconjugated
Catalog No. ABIN6251805
  • Target See all PLAP (ALPP) Antibodies
    PLAP (ALPP) (Placental Alkaline Phosphatase (ALPP))
    Reactivity
    • 125
    • 22
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 73
    • 52
    • 2
    Mouse
    Clonality
    • 68
    • 58
    Monoclonal
    Conjugate
    • 67
    • 11
    • 6
    • 6
    • 6
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This PLAP antibody is un-conjugated
    Application
    • 92
    • 54
    • 52
    • 35
    • 21
    • 17
    • 15
    • 13
    • 11
    • 7
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purification
    Protein G affinity chromatography
    Immunogen
    Recombinant full-length human ALPP protein was used as the immunogen for the placental Alkaline Phosphatase antibody.
    Clone
    ALPP-870
    Isotype
    IgG2b kappa
    Top Product
    Discover our top product ALPP Primary Antibody
  • Application Notes
    Flow Cytometry: 0.5-1 μg/million cells in 0.1ml

    Immunofluorescence: 0.5-1 μg/mL

    Immunohistochemistry (FFPE): 0.25-0.5 μg/mL for 30 min at RT (1)

    Prediluted format : incubate for 30 min at RT (2)

    Optimal dilution of the placental Alkaline Phosphatase antibody should be determined by the researcher.

    1. No special pretreatment is required for the immunohistochemical staining of formalin-fixed tissues.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.2 mg/mL
    Buffer
    PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Aliquot and Store at -20C. Avoid freez-thaw cycles.
  • Target
    PLAP (ALPP) (Placental Alkaline Phosphatase (ALPP))
    Alternative Name
    Placental Alkaline Phosphatase (ALPP Products)
    Synonyms
    ECK0378 antibody, JW0374 antibody, psiA antibody, ALP antibody, PALP antibody, PLAP antibody, PLAP-1 antibody, ILC antibody, CTACK antibody, ESkine antibody, Akp2 antibody, alp antibody, zgc:56672 antibody, DDBDRAFT_0205491 antibody, DDBDRAFT_0231570 antibody, DDB_0205491 antibody, DDB_0231570 antibody, ALPI antibody, Actn2lp antibody, Alp antibody, bacterial alkaline phosphatase antibody, alkaline phosphatase, placental antibody, alkaline phosphatase, placental type antibody, C-C motif chemokine ligand 27 antibody, alkaline phosphatase, liver/bone/kidney antibody, alkaline phosphatase antibody, alkaline phosphatase, intestinal antibody, PDZ and LIM domain 3 antibody, phoA antibody, ALPP antibody, LOC100436725 antibody, CCL27 antibody, alpl antibody, alp antibody, ALPI antibody, Pdlim3 antibody, Alpp antibody
    Background
    Reacts with a 70  kDa membrane-bound isozyme (Regan and Nagao type) of placental Alkaline Phosphatase (PLAP) occurring in the placenta during the 3rd trimester of gestation. It is highly specific for PLAP and shows no cross-reaction with other isozymes of alkaline phosphatase. Anti-PLAP reacts with germ cell tumors and can discriminate between these and other neoplasms. Somatic neoplasms e.g. breast, gastrointestinal, prostatic, and urinary cancers may also immunoreact with antibodies to PLAP. Anti-PLAP positivity in conjunction with anti-keratin negativity favors seminoma over carcinoma. Germ cell tumors are usually anti-keratin positive, but they regularly fail to stain with anti-EMA, whereas most carcinomas stain with anti-EMA. Anti-PLAP has been useful in the diagnosis of gestational trophoblastic disease.
    Gene ID
    250
    UniProt
    P05187
You are here:
Support